These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12131912)

  • 1. Case management for pediatric respiratory syncytial virus outcomes.
    Deming LM
    Case Manager; 2002; 13(4):72-4. PubMed ID: 12131912
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of infections caused by respiratory syncytial virus.
    Swedish Consensus Group
    Scand J Infect Dis; 2001; 33(5):323-8. PubMed ID: 11440215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprophylaxis for respiratory syncytial virus.
    Sánchez PJ
    Pediatr Infect Dis J; 2002 May; 21(5):473-8. PubMed ID: 12150195
    [No Abstract]   [Full Text] [Related]  

  • 4. Utilization management opportunities for palivizumab for prophylaxis of respiratory syncytial virus complications in infants.
    Curtiss FR; Fairman KA
    J Manag Care Pharm; 2010; 16(1):59-66. PubMed ID: 20044846
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of respiratory syncytial virus infection.
    Kimpen JL
    Curr Opin Infect Dis; 2001 Jun; 14(3):323-8. PubMed ID: 11964851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric case management for respiratory syncytial virus outcomes.
    Rieve JA
    Case Manager; 2002; 13(2):32-4. PubMed ID: 11901367
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in prevention of respiratory syncytial virus infections.
    Prober CG; Sullender WM
    J Pediatr; 1999 Nov; 135(5):546-58. PubMed ID: 10547241
    [No Abstract]   [Full Text] [Related]  

  • 8. Respiratory syncytial virus infection: clinical features, management, and prophylaxis.
    Greenough A
    Curr Opin Pulm Med; 2002 May; 8(3):214-7. PubMed ID: 11981311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus: concerns and control.
    McCarthy CA; Hall CB
    Pediatr Rev; 2003 Sep; 24(9):301-9. PubMed ID: 12949266
    [No Abstract]   [Full Text] [Related]  

  • 10. Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants: a note of caution.
    Suresh S; Schilling S; Dakin C; Harris MA
    J Paediatr Child Health; 2003 Nov; 39(8):637. PubMed ID: 14629536
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recommendations for the prevention of respiratory syncytial virus in high-risk pediatric groups].
    Janković B; Minić P; Maglajlić-Djukić S; Prekajski N
    Vojnosanit Pregl; 2009 Oct; 66(10):827-9. PubMed ID: 19938762
    [No Abstract]   [Full Text] [Related]  

  • 12. Palivizumab for respiratory syncytial virus prophylaxis.
    Sandritter T
    J Pediatr Health Care; 1999; 13(4):191-5; quiz 196-7. PubMed ID: 10690084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Palivizumab prophylaxis against respiratory syncytial virus. Should its indications be reviewed?].
    Salas Hernández S
    An Pediatr (Barc); 2004 Jan; 60(1):87-8. PubMed ID: 14718137
    [No Abstract]   [Full Text] [Related]  

  • 14. Respiratory syncytial virus: old challenges and new approaches.
    Chávez-Bueno S; Mejías A; Jafri HS; Ramilo O
    Pediatr Ann; 2005 Jan; 34(1):62-8. PubMed ID: 15693217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSV: protecting the littlest patients.
    Lauts NM
    RN; 2005 Dec; 68(12):46-51; quiz 52. PubMed ID: 16411554
    [No Abstract]   [Full Text] [Related]  

  • 16. Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease.
    Feltes TF; Sondheimer HM
    Expert Opin Biol Ther; 2007 Sep; 7(9):1471-80. PubMed ID: 17727335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprophylaxis of respiratory syncytial virus infection.
    Simoes EA
    Indian Pediatr; 2000 Mar; 37(3):243-7. PubMed ID: 10750065
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of respiratory syncytial virus infections with palivizumab].
    Ellingsen BB; Aase SA; Øymar K
    Tidsskr Nor Laegeforen; 2003 Apr; 123(7):941-3. PubMed ID: 12737068
    [No Abstract]   [Full Text] [Related]  

  • 19. Respiratory syncytial virus therapy and prophylaxis: have we finally turned the corner?
    Hegele RG
    Eur Respir J; 2011 Aug; 38(2):246-7. PubMed ID: 21804160
    [No Abstract]   [Full Text] [Related]  

  • 20. Humanized monoclonal antibody for prevention of respiratory syncytial virus infection.
    Storch GA
    Pediatrics; 1998 Sep; 102(3 Pt 1):648-51. PubMed ID: 9738192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.